Oncotarget has announced that its peer-reviewed research publications will be indexed in Meta, a world-renowned database of scientific literature, alongside other Impact Journal publications. Meta was acquired by the Chan Zuckerberg Initiative in an effort to make Meta's artificial intelligence (AI) technologies available to enhance scientists' ability to search, read, and tie together millions of scientific papers.
The partnership enables Oncotarget's publications to be quickly disseminated to scientists around the world. The expansion of Impact Journal's indexing is a huge step for Oncotarget and the scientific community, as it enables Oncotarget's publications to be searchable in an enormous database, and according to Tech Crunch, Meta assists scientists with analysis on their areas of research along with determination of experiments previously performed and finding new opportunities for investigation.
A similar idea about new knowledge generated through reviewing accumulated results and linking it into testable chains and networks was published by the Co-Editor-in-Chief of Oncotarget, Mikhail Blagosklonny, and the Editorial Board Member, Arthur Pardee, in 2002. DOI:10.1038/416373a
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
